Koko Sugawara

944 citations
20 papers · 762 indexed · h-index 16
Topics
Microbial Natural Products and Biosynthesis (10 papers)Chemical Synthesis and Analysis (5 papers)Antimicrobial Peptides and Activities (3 papers)

In The Last Decade

Koko Sugawara

20 papers receiving 738 citations

Peers

Koko Sugawara
Comparison fields: 5 of 77
  • Molecular Biology 484
  • Pharmacology 282
  • Organic Chemistry 264
  • Oncology 118
  • Biotechnology 90
Replace Matthew J. LaMarche with:
Matthew J. LaMarche United States
SOICHIRO TODA United Kingdom
T. Ogawa Japan
Makoto Yoshihama Japan
Kei-Ichi Numata Japan
Toshio Takatsu Japan
Jutta Wanner United States
Toshiaki Sunazuka Japan
K. Eckardt Germany
Pascal Belin France
Koko Sugawara relative to Matthew J. LaMarche United States Matthew J. LaMarche's profile →
Citations per field
00.5×1.5×
Matthew J. LaMarche · 1×
Citations per year

Countries citing papers authored by Koko Sugawara

Since Specialization
Citations

This map shows the geographic impact of Koko Sugawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koko Sugawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koko Sugawara more than expected).

Fields of papers citing papers by Koko Sugawara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koko Sugawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koko Sugawara. The network helps show where Koko Sugawara may publish in the future.

Co-authorship network of co-authors of Koko Sugawara

This figure shows the co-authorship network connecting the top 25 collaborators of Koko Sugawara. A scholar is included among the top collaborators of Koko Sugawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koko Sugawara. Koko Sugawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 37
2 18
3 43
4 22
5 29
6 27
7 169
8 77
9 6
10 39
11 81
12 29
13 31
14 45
15 22
16 12
17 30
18 26
19 9
20 10

About Koko Sugawara

Koko Sugawara is a scholar working on Pharmacology, Toxicology and Microbiology, having authored 20 papers that have together received 762 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (10 papers), Chemical Synthesis and Analysis (5 papers) and Antimicrobial Peptides and Activities (3 papers). The work is most often cited by research in Pharmacology (282 citations), Toxicology (40 citations) and Biotechnology (90 citations). Koko Sugawara has collaborated with scholars based in Japan, Germany and United Kingdom. Frequent co-authors include MASATAKA KONISHI, TOSHIKAZU OKI, Yuji Nishiyama, Koji Tomita, SOICHIRO TODA, Hideo Kamei, Haruaki Yamamoto, Hiroshi Kawaguchi, Masami Hatori and Minoru Hanada. Their work appears in journals such as FEBS Letters, The Journal of Organic Chemistry and The Journal of Antibiotics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026